Skip to content

Perioperative Fluid Management: Goal-directed Versus Restrictive Strategy

Perioperative Fluid Management: Goal-Directed Therapy vs. Restrictive Approach, a Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02625701
Enrollment
400
Registered
2015-12-09
Start date
2012-01-31
Completion date
2019-09-30
Last updated
2019-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication, Postoperative

Keywords

operative mortality, myocardial infarct, arrhythmia, heart failure, stroke, pneumonia, atelectasis, acute lung injury, surgical site infection, acute kidney injury, body weight

Brief summary

There is no ideal cookbook recipe for fluid prescription that would fit every surgical patient. In this study, the investigators working hypothesis is that the adoption of an integrative algorithm for perioperative fluid and haemodynamic management would improve clinical outcome and reduce hospital resource utilization in noncardiac surgical procedures (major-to-intermediate level of stress. Two intraoperative fluid strategies will be compared: Restrictive vs. goal-directed therapy (GDT). In the GDT group, haemodynamic information will be obtained by a flow monitoring device coupled with standard heart rate and blood pressure monitoring.

Detailed description

The rationale of minimizing body weight gain and avoiding unnecessary fluid compensation of the third compartment is now well justified and achievement of supra-normal oxygen delivery values is likely not necessary in most surgical patients. Therefore,it would be tempting to adopt fluid restriction protocols given the potentials of better wound healing, faster return of bowel function and shorter hospital stay after major surgical procedures. Although dynamic flow indices of volume responsiveness have been validated in critically-ill patients, concerns have been raised regarding the risk of overzealous fluid administration in non-critically-ill patients undergoing elective surgery. To date, RCTs comparing fluid regimen (liberal versus restrictive or liberal versus GDT) have yielded controversial results with no consensus regarding appropriate fluid administration in the perioperative period. Interestingly, restrictive protocols have been associated with more frequent adverse events (e.g., nausea, vomiting) following minor surgical procedures and concerns have been raised regarding the possibility of tissue hypoperfusion leading to end-organ dysfunction.

Interventions

Keep normovolemia with basal crystalloids infusion (3-6 ml/kg/h) and compensate additional fluid losses with colloids or crystalloids.

Optimize CO with additional fluid according to dynamic indices (PPV, SVV, Stroke volume)

Sponsors

University Hospital, Geneva
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Patients, clinical care givers and assessors are blinded to the the treatment (GDT or restrictive). Sealed enveloppes contain the patient' identification number. A person not involved in the study prepare the enveloppes with the identification number. Investigators who are assessing the postoperative study outcomes are blinded to the treatment arms

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patient * elective noncardiac surgery (moderate-high-risk) lasting \> 2h hours (, gastrectomy, pancreatectomy, nephrectomy, radical cystectomy, hepatic resection, open colonic or rectal surgery)

Exclusion criteria

* end-stage organ failure (hemofiltration/dialysis; Child-Pugh class C or MELD score \>22; predicted forced expiratory volume \< 30%, severe heart failure) * life expectancy \< 24h * psychiatric disorders or unability to give independent consent to the study

Design outcomes

Primary

MeasureTime frameDescription
composite index of serious postoperative adverse eventsfrom date of surgery till hospital discharge or 30-day postoperativeearly postoperative major outcomes: mortality, cardiovascular, respiratory, renal and infectious complications

Secondary

MeasureTime frameDescription
body weight changes (kg, postoperative value - preoperative value)from date of surgery till hospital discharge, or 30-day postoperativecomparison of body weight (preop versus postop value, kg)
fluid balanceintra-operative and first 24hours after surgeryamount of fluids (ml) infused, amount of fluid losses change in body weight
Acute Kidney Injury based on RIFLEfrom the day before to 3 days after surgerymeasurements of creatinine (preoperative, postoperative day 1, 2, 3 after surgery) and assessing the changes in glomerular filtration rate (%)
Sequential Organ Failure Assessment (SOFA)from date of surgery till hospital discharge, up to 15 weeks after date of surgeryscoring the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems
tissue oximetry (%)intraoperative period, day of surgeryMonitoring of oxygen delivery/utilization in the brain area with near-infra-red spectroscopy (NIRS)
survivalsurvival 1-3 years after surgerypatients (family, next of kin, doctor) are contacted by phone or mail

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026